Research is a critical part of what we do at Georgetown University Hospital, as we are always searching for innovative ways to treat and manage advanced disease and transplantation surgery.
A Randomized, Open Label, Parallel-Group, Multi-center Trial to Compare the Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Hepatic Resection Surgery Thomas Fishbein, MD
The MedStar Research Institute, Transplant Research Center has as its purpose to enhance patient care through the systematic investigation of therapeutic interventions to prevent organ rejection and to prolong graft function. The research team supports the members of Transplantation Services in their research endeavors by assisting them with:
The Research Center is self-supporting. Clinical studies are funded by pharmaceutical companies, not-for-profit foundations, and the federal government.
Patients who qualify for a study are given the opportunity to participate. The studies are done under the supervision of the Director of Transplantation Dr. Jimmy A. Light. They include:
All of our studies are presented at regional, national, and international meetings and are published in peer-reviewed scientific journals. We are committed to advancing the art and science of transplantation and to improving the quality of patients' lives through systematic investigation.